PUBLIC CONTRACT · 2024
Aquisição de sacituzumab govitecano 200 mg ampolas ao abrigo do acordo quadro 2023/481 dos spms, EPE
- Contract value
- €373,330.00
- Signed on
- 5 April 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10678251PUBLISHED SUBJECT
AQUISIÇÃO DE SACITUZUMAB GOVITECANO 200 MG AMPOLAS AO ABRIGO DO ACORDO QUADRO 2023/481 DOS SPMS, EPE PARA A ULSBM, EPE
Parties involved
- Place of performance
- Portugal, Coimbra, Figueira da Foz
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GILEAD SCIENCES, LDA. · Tax ID 503604704
Values and timeline
- Contract price
- €373,330.00
- Procedure base price
- €373,330.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 19 April 2024
- Award date
- 5 April 2024
- Signing date
- 5 April 2024
- Performance period
- 285 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 481/2023 - Acordo quadro para fornecimento de medicamentos diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6979088
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.